JPMORGAN CHASE & CO

Holdings History for VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Symbol: VYNE on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$85	146	0		$0.58	Q4 2025
30 Sep 2025	0%	0%	$49	146	0		$0.34	Q3 2025
30 Jun 2025	0%	-0%	$241	146	-5,835	-98%	$1.65	Q2 2025
31 Mar 2025	0%	+0%	$9,450	5,981	+5,667	+1800%	$1.58	Q1 2025
31 Dec 2024	0%	0%	$1,052	314	+137	+77%	$3.35	Q4 2024
30 Sep 2024	0%	0%	$332	177	+1	+0.57%	$1.88	Q3 2024
30 Jun 2024	0%	0%	$347	176	+7	+4.1%	$1.97	Q2 2024
31 Mar 2024	0%	0%	$520	169	+23	+16%	$3.08	Q1 2024
31 Dec 2023	0%	0%	$341	146	0		$2.34	Q4 2023
30 Sep 2023	0%	0%	$584	146	+138	+1725%	$4.00	Q3 2023
30 Jun 2023	0%	0%	$32	8	+8	NEW	$4.00	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.